Article

Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands.

Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
Breast Cancer Research and Treatment (Impact Factor: 4.47). 05/2009; 120(2):357-67. DOI: 10.1007/s10549-009-0393-2
Source: PubMed

ABSTRACT To investigate a presumed crosstalk between estrogen receptor alpha (ERalpha) and the TGF-beta signaling pathway in breast cancer, we analyzed the TGF-beta-induced expression of the plasminogen activator inhibitor 1 (PAI-1) gene in ER-positive MCF-7 cells. After siRNA-mediated knock-down of endogenous ERalpha, the transcription level of PAI-1 was upregulated, pointing to an attenuation of TGF-beta signaling by the presence of ERalpha. We verified these findings by a vice versa approach using a primary ER-negative cell model transiently overexpressing either ERalpha or ERbeta. We found that ERalpha, but not ERbeta, led to a strong inhibition of the TGF-beta1 signal, monitored by TGF-beta reporter assays. This attenuation was completely independent of receptor stimulation by beta-estradiol (E2) or inhibition by the pure antagonist ICI 182.780 (ICI). Our results indicate a permanent repression of PAI-1 by ERalpha and suggest a ligand-independent crosstalk between ERalpha and TGF-beta signaling in breast cancer cells.

0 Bookmarks
 · 
223 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Transforming growth factor β (TGF-β) signaling pathway is a major pathway in cellular processes such as cell growth, apoptosis, and cellular homeostasis. Activated signaling pathway by 17beta-estadiol (E2) appeared to inhibit TGF-β signaling pathway by cross-talking with TGF-β components in estrogen receptor (ER)-positive cells. In this study, we examined the inhibitory effects of endocrine disrupting chemicals (EDCs), including 4-nonylphenol (NP), 4-otylphenol (OP), bisphenol A (BPA) and benzophenon-1 (BP-1), in TGF-β signaling pathway in BG-1 ovarian cancer cells expressing estrogen receptors (ERs). The transcriptional and translational levels of TGF-β related genes were examined by reverse transcription-PCR (RT-PCR), Western blotting analysis, and xenograft mouse models of ovarian cancer cells. As results, treatment with NP, OP, and BPA induced the expressions of snoN, a TGF-β pathway inhibitor, and c-Fos, a TGF-β target transcription factor. Treatment with NP, BPA and BP-1 resulted in decreased phosphorylation of Smad3, a downstream target of TGF-β. These results indicate that NP and BPA may stimulate the proliferation of BG-1 cells via inhibition of TGF-β signaling pathway. In a xenograft mouse model, transplanted BG-1 ovarian cancer cells showed significantly decreased phosphorylation of Smad3 and increased expression of snoN in the ovarian tumor masses following treatment with E2, NP, or BPA. In parallel with an in vitro model, the expressions of these TGF-β signaling pathway were similarly regulated by NP or BPA in a xenograft mouse model. These results support that the existence of an unproven relationship between EDCs/ER alpha and TGF-β signaling pathway, and a further study is required in order to verify more profound and distinct mechanism(s) for disturbance of TGF-β signaling pathway by diverse EDCs.
    Chemical Research in Toxicology 12/2013; · 3.67 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The present experiments were performed to determine the roles of estrogen receptors α and β (ERα and ERβ) in normal and neoplastic development in the mouse mammary gland. In wild-type mice, in vivo administration of estradiol (E) + progesterone (P) stimulated mammary ductal growth and alveolar differentiation. Mammary glands from mice in which the ERβ gene has been deleted (βERKO mice) demonstrated normal ductal growth and differentiation in response to E + P. By contrast, mammary glands from mice in which the ERα gene has been deleted (αERKO mice) demonstrated only rudimentary ductal structures that did not differentiate in response to E + P. EGF demonstrates estrogen-like activity in the mammary glands of αERKO mice: treatment of αERKO mice with EGF + P (without E) supported normal mammary gland development, induced expression of progesterone receptor (PR), and increased levels of G-protein-coupled receptor (GPR30) protein. Mammary gland development in βERKO mice treated with EGF + P was comparable to that of wild-type mice receiving EGF + P; EGF had no statistically significant effects on the induction of PR or expression of GPR30 in mammary glands harvested from either wild-type mice or βERKO mice. In vitro exposure of mammary glands to 7,12-dimethylbenz[a]anthracene (DMBA) induced preneoplastic mammary alveolar lesions (MAL) in glands from wild-type mice and βERKO mice, but failed to induce MAL in mammary glands from αERKO mice. Microarray analysis of DMBA-treated mammary glands identified 28 functional pathways whose expression was significantly different in αERKO mice versus both βERKO and wild-type mice; key functions that were differentially expressed in αERKO mice included cell division, cell proliferation, and apoptosis. The data demonstrate distinct roles for ERα and ERβ in normal and neoplastic development in the mouse mammary gland, and suggest that EGF can mimic the ERα-mediated effects of E in this organ.
    PLoS ONE 01/2014; 9(11):e113175. · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Der pleiotrope Wachstumsfaktor „transforming growth factor β“ (TGF-β) ist in diverse Signalwege involviert und kann eine Vielzahl von Zellantworten beeinflussen. Bei Entstehung und Karzinogenese des Prostatakarzinoms (PCa) können dies sowohl antionkogene Mechanismen (Wachstumshemmung, Apoptose) als auch proonkogene Prozesse sein (Proliferation, Zellbeweglichkeit, Modulierung der Tumorumgebung). Die ursprünglich antiproliferative Wirkung von TGF-β wird dabei im Verlauf der Tumorprogression immer mehr von proonkogenen Effekten überlagert, die häufig durch die Interaktion mit proliferativen Signalkaskaden wie „Mitogen-activated protein-kinase-“ (MAP-Kinase-) oder Androgenrezeptor- (AR-)Signalwegen vermittelt werden. Obgleich TGF-β ein wichtiger Modulator der PCa-Progression ist, sind die zugrundeliegenden molekular-pathologischen Prozesse bisher nur unvollständig verstanden.
    Der Urologe 52(3). · 0.46 Impact Factor

Full-text (2 Sources)

Download
41 Downloads
Available from
May 22, 2014